A Phase 2, Multicenter, Randomized, Double-blind, 52-week Study, to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Uncontrolled Moderate to Severe Asthma
A Phase 2, Multicenter, Randomized, Double-blind, 52-week Study, to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Uncontrolled Moderate to Severe Asthma
The purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with moderate-to-severe asthma.
Study participation will last approximately 65 weeks, including screening, treatment, and follow-up periods.
Inclusion Criteria:
Exclusion Criteria:
Participants are excluded from the study if any of the following criteria apply:
Known pre-existing, clinically important lung condition other than asthma, including but not limited to:
Have a current or recent acute, active infection. For at least 30 days before screening visit and up to the randomization visit.
LillyTrials@Lilly.com317-615-4559
clinical_inquiry_hub@lilly.com
Tempe, Arizona 85281, United States
602-910-3343
Colorado Springs, Colorado 80907, United States
Nashville, Tennessee 37203, United States
Ciudad de Buenos Aires, C1012AAR, Argentina
541154143028
Baotou, 014010, China
Wenzhou, 315100, China
Wuhan, 430030, China
Aix-en-Provence, 13100, France
Essen, 45239, Germany
Frankfurt, 60596, Germany
Rohtak, 124001, India
Guadalajara, 44650, Mexico
949-791-8599
310-265-1623
352-629-5800
850-477-7900
813-631-4024
270-684-6144
702-597-9825
908-303-9909
630-981-1261
412-833-4051
+541168893232
08003450697
+549115 800 5058
+5493794391031
+5493416008195
+54 9 2234 24-0652
541131077237
54 341 397379
543424564943
5541 3208 6500
55 54 3581 1831
+552125277979
551535194909
3658859086
604-373-4954
4169449602
(519) 252-4448
13101363078
13576030963
13132088076
0661073507
0141708160
0684629275
+330557656039
004926228983390
+493044048226
00492014334503
00492014334503
4969695972580
0049 40 46095194
034160050650
0049 69 247433849
+91-8390628800
09910425552
+91-9028560535
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
81120023812
4491114337
3331200700
9992855178
529999204004
2299327808
0031365468346
0031-76-5952383
0243658755
0104616619
+31575592322
0031 88 6243254
48124223271
+ 48 696 049 029
+48616562160
+48 601 751 713